114 related articles for article (PubMed ID: 7520882)
1. Interleukin-4 inhibits proliferation of human leukemic megakaryoblast cell line MHH 225.
Hassan HT; Grell S; Borrmann-Danso U; Freund M
Hematol Oncol; 1994; 12(2):61-6. PubMed ID: 7520882
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture.
Hassan HT; Petershofen E; Lux E; Fonatsch C; Heil G; Freund M
Ann Hematol; 1995 Sep; 71(3):111-7. PubMed ID: 7548328
[TBL] [Abstract][Full Text] [Related]
3. Myeloid differentiation of purified CD34+ cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and interleukin-3.
Egeland T; Steen R; Quarsten H; Gaudernack G; Yang YC; Thorsby E
Blood; 1991 Dec; 78(12):3192-9. PubMed ID: 1720697
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
6. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
Gazzola MV; Collins NH; Tafuri A; Keever CA
Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
8. CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential.
Schmitt C; Ktorza S; Sarun S; Blanc C; De Jong R; Debre P
Blood; 1993 Dec; 82(12):3675-85. PubMed ID: 7505122
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a factor-dependent acute leukemia cell line with translocation (3;3)(q21;q26).
Oval J; Jones OW; Montoya M; Taetle R
Blood; 1990 Oct; 76(7):1369-74. PubMed ID: 1698479
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 as a growth regulator of clonogenic cells in acute myelogenous leukemia in suspension culture.
Miyauchi J; Clark SC; Tsunematsu Y; Shimizu K; Park JW; Ogawa T; Toyama K
Leukemia; 1991 Feb; 5(2):108-15. PubMed ID: 1708433
[TBL] [Abstract][Full Text] [Related]
11. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
[TBL] [Abstract][Full Text] [Related]
12. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.
Chiba S; Takaku F; Tange T; Shibuya K; Misawa C; Sasaki K; Miyagawa K; Yazaki Y; Hirai H
Blood; 1991 Nov; 78(9):2261-8. PubMed ID: 1834251
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor and interleukin 4 induce differentiation in the U-937 human monocytic leukemia cell line.
Koss A; Lucero G; Koziner B
Leuk Lymphoma; 1996 Jun; 22(1-2):163-71,follow.186,color plate XIV-V. PubMed ID: 8724544
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and differentiative effects of recombinant interleukin-4 on a granulocyte colony-stimulating factor-dependent myeloblastic leukemic cell line.
Imai Y; Nara N; Tohda S; Nagata K; Suzuki T; Nagasawa M; Murohashi I; Aoki N
Blood; 1991 Jul; 78(2):471-8. PubMed ID: 2070083
[TBL] [Abstract][Full Text] [Related]
15. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
[TBL] [Abstract][Full Text] [Related]
16. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA
Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936
[TBL] [Abstract][Full Text] [Related]
17. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
18. Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis.
Mouthon MA; Freund M; Titeux M; Katz A; Guichard J; Breton-Gorius J; Vainchenker W
Blood; 1994 Aug; 84(4):1085-97. PubMed ID: 7519473
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes.
Thomas X; Guyotat D; Campos L; Shi ZH; Vila L; Ehrsam A; Fiere D
Leuk Res; 1991; 15(1):29-36. PubMed ID: 1705306
[TBL] [Abstract][Full Text] [Related]
20. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
